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StriatumPathological gambling (PG) is a behavioural addiction associated with elevated impulsivity and suspected
dopamine dysregulation. Reduced striatal dopamine D2/D3 receptor availability has been reported in drug ad-
diction, and may constitute a premorbid vulnerability marker for addictive disorders. The aim of the present
study was to assess striatal dopamine D2/D3 receptor availability in PG, and its association with trait impul-
sivity. Males with PG (n=9) and male healthy controls (n=9) underwent [11C]-raclopride positron emis-
sion tomography imaging and completed the UPPS-P impulsivity scale. There was no signiﬁcant difference
between groups in striatal dopamine D2/D3 receptor availability, in contrast to previous reports in drug
addiction. However, mood-related impulsivity (‘Urgency’) was negatively correlated with [11C]-raclopride
binding potentials in the PG group. The absence of a group difference in striatal dopamine binding implies
a distinction between behavioural addictions and drug addictions. Nevertheless, our data indicate heteroge-
neity in dopamine receptor availability in disordered gambling, such that individuals with high mood-related
impulsivity may show differential beneﬁts from dopamine-based medications.
© 2012 Elsevier Inc. Open access under CC BY license.Introduction
Pathological Gambling (PG) is a DSM-IV impulse control disorder
with substantial clinical and aetiological overlap with drug addiction,
prompting a re-conceptualisation of PG as a ‘behavioural addiction’
(Bowden-Jones and Clark, 2011; Frascella et al., 2010). Neurobiologi-
cal models of drug addiction emphasise the dysregulation of dopa-
mine: many drugs of abuse stimulate dopamine neurotransmission
(Di Chiara and Imperato, 1988), and reductions in dopamine D2/D3
receptor availability have been described in patients dependent
upon a variety of abused drugs (Fehr et al., 2008; Heinz et al., 2004;
Martinez et al., 2004; Volkow et al., 1997, 2001). It is unclear whether
these alterations reﬂect a consequence of long-term drug use, or a
pre-existing vulnerability to addiction. Consistent with a vulnerability
marker, ‘drug-liking’ is associated with low D2/D3 receptor availability
(Volkow et al., 1999), and a rodent strain inbred to be behaviourallyntal Psychology, University of
 license.impulsive displayed rapid acquisition of cocaine self-administration
and reduced striatal dopamine D2/D3 receptor availability prior to
drug exposure (Dalley et al., 2007). As a form of addiction with pre-
sumably negligible toxicity, studies of PG may enable further study
of vulnerability models in humans, and help arbitrate issues of cause
and consequence (Verdejo-Garcia et al., 2008). Indeed, there are a
number of indications of dopamine dysregulation in PG. Peripheral
dopamine markers in cerebrospinal ﬂuid are dysregulated in problem
gamblers (Bergh et al., 1997;Meyer et al., 2004), as are fMRI responses
in dopamine-rich circuitry during performance on gambling tasks
(Chase and Clark, 2010; Reuter et al., 2005), although the direction
of effect is inconsistent. In addition, dopamine-agonist medications
for Parkinson's Disease appear capable of triggering disordered gam-
bling as a side-effect (Voon et al., 2009).
Positron Emission Tomography (PET) imagingwith [11C]-raclopride
provides a means of quantifying striatal dopamine transmission in
the living human brain. [11C]-raclopride has recently been used in
four PET studies scanning participants with disordered gambling in
dynamic (i.e. task-related) designs (Joutsa et al., 2012; Linnet et al.,
2011; O'Sullivan et al., 2011; Steeves et al., 2009). Two of these stud-
ies were in patients with Parkinson's Disease (O'Sullivan et al., 2011;
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ciated impulse control disorders are functionally related to the pri-
mary neuropathology of the disease (Voon et al., 2009). The other
two studies, in primary PG, both used complex decision-making /
gambling tasks where the baseline scan involved a sensorimotor
control task (Joutsa et al., 2012; Linnet et al., 2011). Only one study
(Steeves et al., 2009) found evidence for reduced striatal dopamine
D2/D3 receptor availability in the group with disordered gambling.
The present study examined baseline striatal dopamine D2/D3 recep-
tor availability in treatment-seeking patients with a primary diagno-
sis of PG, where we hypothesized a reduction in D2/D3 receptor
availability based on prior studies in drug addiction.
We also sought to explore striatal D2/D3 receptor availability in re-
lation to trait impulsivity. Elevated impulsivity is reliably observed
across both drug addictions and PG (Verdejo-Garcia et al., 2008), and
is also seen to prospectively predict the development of substance
use and gambling problems (Slutske et al., 2005). We recently used
the UPPS-P impulsivity scale (Cyders et al., 2007) to assess subfacets
of the impulsivity construct in patients with PG attending the UK Na-
tional Problem Gambling Clinic (Michalczuk et al., 2011). Signiﬁcant
differenceswere observed between the PG group and healthy controls
on several of the UPPS-P subscales including Urgency – the tendency
to be impulsive during negative or positive mood states (‘rash impul-
sivity’) – and aspects of ‘narrow’ impulsivity (Lack of Planning and
Lack of Perseverance). However, the effect sizes for the Urgency differ-
ences were markedly higher than for the narrow impulsivity facets,
prompting the conclusion that mood-related impulsivity is especially
relevant in the context of disordered gambling (Michalczuk et al.,
2011). In light of these observations, our individual differences analy-
ses focussed a priori on the two Urgency subscales (Negative Urgency
and Positive Urgency) as predictors.
Methods and materials
Participants
Nine male volunteers with PG (mean age 35.3 years, sd 9.0, range
25–49) were compared against nine male healthy controls (mean age
37.2, sd 5.6, range 30–46). A tenth PG subject was recruited but not
available for analysis due to radiochemistry failure. Control volunteer
baseline scans were identiﬁed from two previous studies (Egerton et
al., 2010; Stokes et al., 2010) using a normative database of raclopride
scans held at the MRC Clinical Sciences Centre, and did not differ from
the PG group in age (t16=0.53, p=.602). The PG participants were
educated to at least high-school level with IQ estimates in the healthy
range (Wechsler Adult Scale for Intelligence: mean 116, sd 10.8; Na-
tional Adult Reading Test: mean 117, sd 5.7); past work indicates no
consistent relationship between intelligence and dopamine binding
levels. All volunteers provided written informed consent for the
study, whichwas approved both by theHammersmith Research Ethics
Committee and the Administration of Radioactive Substances Adviso-
ry Committee, UK.
PG participants were recruited from the National Problem Gam-
bling Clinic, Central North West London NHS Foundation Trust. Six
volunteers were imaged shortly prior to, or during, a ten session course
of cognitive-behavioural therapy and three had recently completed
treatment. All nine volunteers had a recent history of active gambling.
DSM-IV diagnosis of PG was conﬁrmed with the Massachusetts Gam-
bling Screen (MAGS; mean 9.8, sd 2.2, range 5–12) (Shaffer et al.,
1994), administered by an assistant psychologist at the time of treat-
ment initiation. The diagnosiswas corroboratedwith the ProblemGam-
bling Severity Index (Ferris and Wynne, 2001), a self-report scale also
given at the beginning of treatment (mean 18.4, sd 5.7, range 8–24; a
score of 8 or above indicates problem gambling). The delay between
the clinical evaluation and the PET scan was 2–8 months in 8/9 partici-
pants, and 23 months in one PG who was scanned post-treatment.Psychiatric co-morbidities were assessed in the PG participants by
a semi-structured interview using the ICD-10, in conjunction with
the computerised version of theMini International Neuropsychiatric In-
terview (e-MINI v2.0; Medical Outcome Systems, Jacksonville, Florida)
(Sheehan et al., 1998). Two volunteers had a previous history of major
depressive disorder, and one volunteer met criteria for current and life-
time major depressive disorder. One volunteer met criteria for previous
alcohol dependence, and a secondmet criteria for previous cannabis de-
pendence. Four volunteerswere current cigarette smokers at the time of
recruitment to the study (Fagerstrom Nicotine Dependence Scale scores
from 6 to 12). Exclusion criteria for the PG groupwere: history of neuro-
logical illness, previous psychiatric admission, current pharmacotherapy
and signiﬁcant physical illness. As such, the detected psychiatric comor-
biditieswere not of sufﬁcient severity to require clinical intervention. All
of the control participants had been previously assessed by a psychiatrist
to exclude current or previous signiﬁcant mental health problems, and
substance dependence as deﬁned by DSM-IV, serious physical illness,
past neurological disorders or previous use of psychotropicmedications.
Gambling activities were assessed in the PG participants using items
1–3 on the South Oaks Gambling Screen (Lesieur and Blume, 1987). Six
participants considered electronic gaming machines (‘Fixed Odds
Betting Terminals’) to represent their problematic form of gambling;
the remaining three considered sports betting (on horses), internet
poker / blackjack, and casino games (roulette) to be most problematic.
On rating the largest amount of money gambled in a single day, ﬁve
endorsed the £1,000-£10,000 bin, and four endorsed over £10,000.
When questioned about gambling-related debts, one gambler refused
to provide debt information, one gambler reported no debt due to use
of personal savings, and current debt in the remaining seven ranged
from £4000–£35,000 (mean £15,714).
Participants completed the UPPS-P Impulsive Behaviour Scale
(Cyders et al., 2007), a 59-item self-report questionnaire with ﬁve
subscales assessing Negative Urgency (e.g. “Sometimes when I feel
bad, I can't seem to stop what I am doing even though it is making
me feel worse”), Positive Urgency (e.g. “When overjoyed, I feel like I
can't stop myself from going overboard”) , (lack of) Planning (e.g. “I
usuallymake upmymind through careful reasoning” — negative load-
ing), (lack of) Perseverance (e.g. “I ﬁnishwhat I start” — negative load-
ing) and Sensation Seeking (e.g. “I would enjoy the sensation of skiing
very fast down a high mountain slope”). We were unable to obtain
UPPS-P data from one of the database control volunteers.Image acquisition and processing
All PET scans were acquired using an ECAT HR+962 scanner (CTI/
Seimens) with an axial ﬁeld of view of 15.5 cm. [11C]-raclopride was
administered as an intravenous bolus injection for PG volunteers, and
for the control volunteers as an initial intravenous bolus followed by
constant infusion, with an infusion length of 85 min for four scans
from the Egerton et al. study (2010) and 100 min for ﬁve scans
from the Stokes et al. study (2010). A 10 min transmission scan was
performed prior to each emission scan to measure and correct for
tissue attenuation. Dynamic emission scans were acquired in three
dimensional mode using a standard acquisition protocol (20 time
frames over 60 min for PG participants, 28 time frames over 85 min
for the Egerton et al. (2010) scans and 38 frames over 100 minutes
for the Stokes et al. (2010) scans). For the PG participants, their scan
involved the presentation of neutral images including landscapes,
household objects and random patterns, but with no motor require-
ment (participants were only scanned once).
All dynamic scans were corrected for head movement using frame
by frame (FBF) realignment (Montgomery et al., 2006). This proce-
dure was applied to all frames to generate an FBF-corrected dynamic
image, whichwas then analysed using an automated region of interest
(ROI) analysis, supplemented by a conﬁrmatory voxelwise analysis.
Table 1
Striatal dopamine D2/3 receptor binding potentials and facets of impulsivity in the
Pathological Gamblers and healthy Controls, with effect sizes reported as Cohen's d.
PG Controls d
Raclopride BPND
Overall striatum 2.46 (0.26) 2.41 (0.21) 0.22
Limbic 2.22 (0.28) 2.24 (0.22) 0.08
Associative 2.38 (0.27) 2.29 (0.23) 0.35
Sensorimotor 2.78 (0.30) 2.76 (0.23) 0.11
UPPS-P impulsivity
Negative Urgency 38.7 (4.33)⁎⁎ 24.9 (4.32) 3.19
Positive Urgency 37.8 (6.10)⁎⁎ 24.6 (6.91) 2.03
(lack of) Planning 29.3 (6.78)⁎ 22.1 (6.53) 1.08
(lack of) Perseverance 22.4 (5.25) 20.8 (3.58) 0.35
Sensation seeking 36.0 (5.87) 33.1 (7.74) 0.43
⁎⁎ pb .005.
⁎ pb .05.
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Striatal and cerebellar ROIs were deﬁned using an atlas comprised
of the three functional subdivisions of the striatum; limbic, asso-
ciative and sensorimotor striatum, and the cerebellum as reference
region. The striatal subdivisions are anatomically analogous to the
ventral striatum (limbic striatum), pre-commissural dorsal putamen,
pre-commissural dorsal caudate and post-commissural dorsal cau-
date (associative striatum) and post-commissural putamen (sensori-
motor striatum) (Martinez et al., 2003). An [11C]-raclopride template
was spatially transformed to the individual PET space of each FBF-
corrected add image (generated from each FBF-corrected dynamic
image using in house software written in Matlab (version 5; The
MathWorks, Inc, Natick, Mass)) within SPM5 (www.ﬁl.ion.ucl.ac.uk/
spm) and the resulting deformation matrix was then applied to the
atlas. The deformed striatal atlas was used to sample counts from dy-
namic [11C]-raclopride images for the PG scans, and from a weighted
steady state add image for control scans, using Analyze 8.0 soft-
ware (www.analyzedirect.com). For PG scans, [11C]-raclopride BPND
values, the ratio of speciﬁcally bound radioligand to that of the non-
displaceable ligand in the cerebellar reference tissue (Innis et al.,
2007), were calculated using a simpliﬁed reference tissue model with
the cerebellum as a reference tissue using in house software written
inMatlab. For control scans, [11C]-raclopride BPND valueswere calculat-
ed as the ratio of striatal counts to cerebellar counts, minus 1, over the
steady state time period. The steady state time period for the bolus infu-
sion scans was deﬁned as commencing at 39 min post-injection and
continuing until the end of the scan, based on estimates of the optimal
timing for the establishment of the steady state (Watabe et al., 2000).
Voxelwise analysis
For the PG volunteer scans, parametric [11C]-raclopride images
were generated from individual dynamic images using a simpliﬁed
reference tissue model with the cerebellum as a reference tissue using
in house software written in Matlab. For control volunteer scans, para-
metric images were generated from individual weighted steady state
add images using image algebra within SPM5 by dividing counts for
each voxel with cerebellar counts and subtracting one. All parametric
images were then normalised to an [11C]-raclopride PET template
using the deformation matrix produced by the spatial transformation
of individual add images to the template. Normalised parametric im-
ageswere then smoothedwithin SPM5using a 6 mmsmoothing kernel.
Statistical analysis
Group differences in impulsivity and regional BPND values were
assessed using multivariate analysis of variance (MANOVA), imple-
mented in SPSS 15 (SPSS, Chicago, Illinois). The relationships between
Urgency and BPND values were assessed using partial correlation coef-
ﬁcients, controlling for age given the robust inﬂuence of age upon
PET measures of D2/D3 receptor availability even within middle adult-
hood (Backman et al., 2000; Kim et al., 2011). A Bonferroni-corrected
statistical threshold of pb .00625 was implemented for the correla-
tional analyses, adjusting for the four striatal regions (overall, limbic,
associative, sensorimotor) and two Urgency scales. For the voxelwise
analysis, correlations between Urgency and [11C]-raclopride binding
were examined using a multiple regression analysis within SPM5, re-
stricted to the striatum, and again included volunteer age as a covar-
iate. A corrected cluster level threshold of pb0.05 with a cluster size
of greater than ten voxels was used for statistical signiﬁcance.
Results
On the UPPS-P impulsivity scale, there was an overall main effect
of group (Wilks’ lambda=0.21, F(5,11)=8.44, p=.002) with thePG group scoring signiﬁcantly higher than healthy controls on the Neg-
ative Urgency (F1,15=43.0, pb .001), PositiveUrgency (F1,15=17.4, p=
.001), and (lack of) Planning (F1,15=4.95, p=.042) subscales. Consis-
tent with our recent report in an extended group of PG recruited
through the same clinic (Michalczuk et al., 2011), the effect sizes were
greatest on the two Urgency subscales (see Table 1). There were no sig-
niﬁcant differences between groups on (lack of) Perseverance (F1,15=
0.59, p=.455) and Sensation Seeking (F1,15=0.76, p=.398).
ROI analysis
There was no overall group difference in [11C]-raclopride BPND
values (Wilks' lambda=0.59, F(4,13)=2.22, p=.124), with no dif-
ference in the overall striatum (F1,16=0.22, p=.64) or in any of the
three striatal subdivisions (limbic F1,16=0.02, p=0.879; associative
F1,16=0.54, p=0.473; sensorimotor F1,16=0.05, p=.819) (see Fig. 1
and Table 1).
Within the PG group, negative correlations (partialling for age)
were observed between Negative Urgency and [11C]-raclopride BPND
values in the overall striatum (Fig. 2A), and limbic and associative
subdivisions of the striatum, each of which was signiﬁcant at the
Bonferroni-corrected level (see Table 2). Positive Urgency was signif-
icantly negatively correlated with BPND values in the overall striatum
(Fig. 2B), and associative subdivision, at the corrected threshold. Neg-
ative Urgency and Positive Urgency were themselves moderately
inter-related (57% shared variance in the PG, 81% shared variance
in controls). The relationships between Urgency and BPND were not
obviously explained the presence of four smokers in the PG group:
the smokers (versus PG non-smokers) displayed negligible differ-
ences in Urgency scores (Negative Urgency mean=39.0 vs 38.4; Pos-
itive Urgency mean=38.8 vs 37.0) and BPND values (limbic striatum
mean=2.20 vs 2.24). Without age included as a partial variable, the
BPND correlations remained signiﬁcant for Negative Urgency (overall
r9=−.875, p=.002; limbic r9=−.846, p=.004; associative r9=
−.868, p=.002) but the correlations against Positive Urgency did
not attain signiﬁcance at the corrected threshold (overall r9=−.703,
p=.035; associative r9=−.738, p=.023). Scores on the ProblemGam-
bling Severity Index (PGSI) were inversely correlated with BPND values
in the associative striatum (partial rho=−.881, p=.004) but were
non-signiﬁcant without age included as a partial variable (r9>−0.45,
p>0.22). PGSI was highly correlated with Positive Urgency (r9=.916,
pb .001) but not signiﬁcantly with Negative Urgency (r9=.627, p=
.071).
BPND values were not signiﬁcantly correlated with the Urgency
measures in the control group (r=−0.36 to 0.31, p>0.42). Indeed,
for the relationship between Negative Urgency and BPND in the limbic
striatum, a direct test of the difference between the correlation co-
efﬁcients conﬁrmed a stronger relationship in the PG group compared
Fig. 1. [11C]-raclopride binding potentials (BPND) for the overall striatum region of
interest (bilateral) and limbic subdivision, for individual cases with Pathological Gam-
bling and healthy controls.
Table 2
Partial correlation co-efﬁcients (controlling for age) in the Pathological Gamblers
between [11C]-raclopride BPND in the striatal regions of interest and trait Urgency
(Negative, Positive). Values in bold were statistically signiﬁcant after Bonferroni cor-
rection for multiple comparisons (p=.006).
PG Controls
Negative Positive Negative Positive
Overall −0.881 −0.941 −0.298 −0.085
Limbic −0.873 −0.857 0.193 0.311
Associative −0.864 −0.968 −0.365 −0.121
Sensorimotor −0.724 −0.720 −0.099 −0.248
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though equivalent tests in the overall striatum for Negative Urgency
(z=1.48, p=.139) and Positive Urgency (z=0.97, p=.332) were
not signiﬁcant. Given the group increase in mood-related impulsivity
in the PG group, we also ran a post-hoc analysis to test for a quadratic
relationship between Urgency and [11C]-raclopride BPND in the
pooled sample, in light of a recent report of an ‘inverted U’ relation-
ship between ventral striatal raclopride binding and trait Sensation
Seeking in healthy volunteers (Gjedde et al., 2010). In regressing
[11C]-raclopride binding values in the limbic striatum (dependent
variable) onto Negative Urgency (predictor variable), the overall
model did not attain signiﬁcance (F(2,14)=3.65, p=.053) but there
was a signiﬁcant effect of the quadratic term (β=−4.07, t=−2.21,
p=.045) (Fig. 2C). These quadratic effects were not observed for Pos-
itive Urgency in the limbic striatum (β=−2.30, t=−1.40, p=.183),
or in the overall striatum (Negative Urgency: β=−3.10, t=−1.56,
p=.141; Positive Urgency: β=−1.75, t=−1.06, p=.306). A direct
attempt to replicate the quadratic effect for Sensation Seeking in the
limbic striatumwas also non-signiﬁcant (β=1.35, t=0.44, p=.664).Voxelwise analysis
The voxelwise group comparison conﬁrmed no signiﬁcant dif-
ferences in [11C]-raclopride binding between PG and controls. The
voxelwise regression against Negative Urgency in the PG group con-
ﬁrmed an inverse relationship with [11C]-raclopride binding in bilat-
eral foci extending from the ventral putamen to the head of caudate
on the right (peak co-ordinates: x=10, y=17, z=−5, cluster
size=227, pb0.001 cluster corrected) and the left caudate body
(peak co-ordinates: x=−10, y=13, z=2, cluster size=103, p=
0.001 cluster corrected). The regression against Positive Urgency
yielded bilateral foci extending from the nucleus accumbens and theFig. 2. Correlations in Pathological Gamblers between [11C]-raclopride BPND in overall stria
ship between [11C]-raclopride BPND in limbic striatum and Negative Urgency in the pooledventral putamen through to the caudate body on the right (peak co-
ordinates: x=21, y=15, z=−5, cluster size =409, pb0.001 cluster
corrected) and the left caudate and putamen (peak co-ordinates: x=
−25, y=13, z=−2, cluster size=297, pb0.001 cluster corrected)
(see Fig. 3). To assess the speciﬁcity of these correlations to mood-
related impulsivity, we also entered (lack of) Planning as a predictor
of [11C]-raclopride binding; no supra-threshold voxels were detected.
Discussion
We detected no differences in striatal dopamine D2/D3 receptor
availability between males with PG attending a specialist treatment
service, and age-matched male healthy controls. In addition to quan-
tifying overall striatal D2/D3 receptor availability, the ROI analysis also
examined receptor availability in three functional subdivisions of the
striatum. The limbic subdivision comprises the nucleus accumbens,
ventral putamen and ventral caudate, and is implicated extensively
in addictive disorders including disordered gambling (Linnet et al.,
2011; O'Sullivan et al., 2011; Steeves et al., 2009). Our observation
of no differences in baseline striatal dopamine D2/D3 receptor avail-
ability between PG participants and controls is consistent with two
recent [11C]-raclopride studies that assessed the change in binding
as PG subjects performed different decision-making / gambling tasks
(Joutsa et al., 2012; Linnet et al., 2011), and with a third PET study
comparing patients with Parkinson's Disease with and without im-
pulse control disorders including PG, during the viewing of reward-
related images (O'Sullivan et al., 2011). We were unable to substanti-
ate the reduction in BPND values reported by Steeves et al (2009) in 7
cases with Parkinson's Disease, with dopamine-agonist induced PG. It
should be noted that their baseline scans involved motor selection
(serial choice between four card decks with meaningless feedback),
which could distort estimates of baseline availability (Egerton et al.,
2009).
Several possible inferences may be drawn from our ﬁndings in PG.
First, the reductions in dopamine D2/D3 receptor availability previous-
ly described in substance users (Fehr et al., 2008; Heinz et al., 2004;
Martinez et al., 2004; Volkow et al., 1997, 2001) may be precipitatedtum and UPPS-P Negative Urgency (A) and Positive Urgency (B). C: Quadratic relation-
group of pathological gamblers (ﬁlled circles) and healthy controls (open circles).
Fig. 3. Results of voxelwise regression of [11C]-raclopride BPND in the Pathological
Gamblers, showing negative association with Negative Urgency (A) (y=+15, z=−5)
and Positive Urgency (B) (y=+15, z=−5).
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selves, and not aligned with the premorbid vulnerability to addictive
disorders. Consistent with this account, D2 receptor availability was
negatively correlated with the duration of stimulant abuse in a pri-
mate experimental model (Nader et al., 2006). An alternative inter-
pretation is that reductions in dopamine binding may represent a
risk factor for drug addiction that does not generalise to PG as a behav-
ioural addiction. Reduced dopamine receptor availability was previ-
ously reported in obesity (Wang et al., 2001), as another candidate
behavioural addiction. Of course, our ﬁndings in no way preclude the
possibility of changes other neurotransmitter systems in PG, such as
glutamate, GABA or serotonin (Leeman and Potenza, 2012), or indeed
changes in other aspects of dopamine transmission such as release
(Linnet et al., 2011), reuptake (Cilia et al., 2010) or metabolism
(Bergh et al., 1997). A second inference from our ﬁndings is that any
dopamine release induced by the chronic schedules of winning and
losing experienced by problem gamblers (e.g. Zald et al., 2004) may
not be sufﬁcient to down-regulate striatal D2/D3 receptor availability.
Nevertheless, within the group of gamblers, [11C]-raclopride
binding was negatively correlated with impulsivity, an established
risk factor for problem gambling (Slutske et al., 2005) and substance
use disorders (Ersche et al., 2010). The facet of impulsivity that we
identify as predictive of striatal dopamine binding was Urgency (or
‘rash impulsiveness’), the tendency to commit impulsive acts under
intense mood states. Case–control comparisons on the Urgency facet
yielded stronger effect sizes than ‘narrow’ impulsivity (i.e. lack of
planning, lack of perseverance), which was also seen in a larger
group recruited from the same clinical setting (Michalczuk et al.,
2011). The lack of planning subscale did not predict striatal dopamine
binding in the voxelwise analysis. Urgency scores predict transitions
into problem gambling, substance abuse and other risky behaviours
in college samples (Cyders and Smith, 2008). Little is known about
the brain systems that regulate this speciﬁc facet of impulsivity, al-
though a recent magnetic resonance spectroscopy study reported Ur-
gency correlations with GABA levels in dorsolateral prefrontal cortex
(Boy et al., 2011), and rodent data demonstrate regulation of striatal
dopamine levels by cortical GABA (Matsumoto et al., 2005). In thePG group, both negative and positive aspects of Urgency predicted
striatal dopamine D2/D3 receptor availability. These relationships
were seen in the overall striatal ROI as well as the limbic (Negative Ur-
gency) and associative (both Negative and Positive Urgency) striatal
subdivisions, and were conﬁrmed in the voxelwise analysis. Negative
and Positive Urgency scores were themselves inter-related, although
it remains unclear whether individual patients with PG are similarly
vulnerable to positive (e.g. euphoria) and negative (e.g. boredom, de-
pression) emotional triggers (Blaszczynski and Nower, 2002; Stewart
and Zack, 2008).
The relationship between Urgency and dopamine receptor avail-
ability was not manifested in the small group of healthy controls test-
ed here. Indeed, the coefﬁcient for Negative Urgency in the limbic
striatum was signiﬁcantly stronger in the PG group than the controls.
In humans with methamphetamine dependence, striatal D2/D3 recep-
tor availability was also negatively correlated with trait impulsivity
(Lee et al., 2009). In light of a recent report in healthy participants
that illustrated a quadratic relationship between ventral striatal
[11C]-raclopride binding and trait Sensation Seeking (Gjedde et al.,
2010), we performed a post-hoc analysis to test a similar effect for
trait Urgency in our pooled sample of PG and healthy controls. We
replicated the ‘inverted U’ (or Yerkes-Dodson) effect in the limbic
striatum, as a function of Negative Urgency. This indicates that both
high and low levels of mood-related impulsivity are associated with
low striatal raclopride binding, and that BPND is maximal in the
mid-range of the distribution.
In principle, lowered BPND may reﬂect decreases in the expression
of striatal D2/D3 dopamine receptors and/or increases in synaptic
dopamine levels. A study using alpha-methyl paratyrosine (AMPT)
to deplete dopamine in cocaine-dependent subjects indicated reduced
receptor availability coupled with reduced extracellular dopamine
levels under baseline conditions (Martinez et al., 2009). However, pre-
liminary work in PG has indicated increased task-related dopamine
release in a subset of PG participants who reported task-related ex-
citement (Linnet et al., 2011). It is conceivable that low BPND in low
impulsives may be driven by reduced D2/D3 receptor availability,
whereas low BPND in high impulsives may be driven by both reduced
receptor availability and elevated extracellular dopamine (Gjedde et
al., 2010). Increases in dopamine release may also be associated with
compensatory down-regulation of (midbrain) autoreceptor availabil-
ity, as detected with the [18F]-fallypride ligand (Buckholtz et al.,
2010). In the present data, some caution is warranted by the fact
that the quadratic term was driven primarily by the PG participants
falling on the right-hand, descending limb, coupled with the pro-
nounced trait difference in that group. To clarify these relationships,
further studies are needed employing multiple markers of dopamine
function across the full range of the impulsive trait, but we would rec-
ommend that future studies consider both linear and quadratic indi-
vidual differences throughout the dopamine pathway.
As further limitations of the present study, our group sizes were
small and therefore the study was not adequately powered to detect
small effect sizes. Based on the effect size for the overall striatum
(Cohen's d=0.22), two groups of at least 350 participants would be
needed to detect a statistically signiﬁcant difference. Second, the use
of healthy controls from a normative database imposed some minor
procedural differences between the two groups: the PG subjects
were presented with neutral images during their scan (albeit with
no response requirement), and the PG subjects received a bolus injec-
tionwhereas the controls received a bolus plus infusion. Priorwork in-
dicates that [11 C]-raclopride binding values generated by the bolus
only approach are almost identical to binding values generated by a
bolus-infusion approach in the same volunteers (Carson et al., 1997;
Ito et al., 1998). In the PG participants, there was a degree of heteroge-
neity in the timing of the scan relative to treatment (most but not
all were scanned pre-treatment), and psychiatric comorbidities were
present in four participants. Post-hoc analyses indicated that our
45L. Clark et al. / NeuroImage 63 (2012) 40–46effects were at least not attributable to smoking status (Busto et al.,
2009; c.f. Fehr et al., 2008). Psychiatric comorbidities are of course
highly prevalent in PG (Kessler et al., 2008) and the inclusion of such
cases does enhance the generalizability of our ﬁndings.
In terms of clinical application, it is notable that while the dopa-
mine agonist pramipexole and partial agonist aripiprazole have
been implicated in the initiation of disordered gambling (Smith et
al., 2011; Voon et al., 2009), dopamine D2 receptor antagonists such
as olanzapine have as yet failed to demonstrate overall efﬁcacy in
PG treatment trials (Fong et al., 2008; McElroy et al., 2008). Within
groups of healthy participants, baseline dopamine availability inﬂu-
ences the action of dopaminergic agents in accordance with the
inverted U model (Cools and D'Esposito, 2011), and thus our ﬁndings
of heterogeneity in dopamine dysregulation in disordered gambling
imply that individuals with high mood-related impulsivity may
show differential beneﬁts from dopamine-based medications. For
example, if low [11 C]-raclopride binding in high impulsive gamblers
is attributable to increased synaptic dopamine (Gjedde et al., 2010),
these individuals may be respond preferentially to dopamine block-
ade. The quadratic relationships with individual differences certainly
imply that multiple dopaminergic mechanisms may be at work in
addictive disorders (Buckholtz et al., 2010; Cilia et al., 2010; Gjedde
et al., 2010).
Disclosures
L Clark declares consultancy for Cambridge Cognition plc. AR
Lingford-Hughes has received honoraria from Janssen-Cilag, Pﬁzer,
Servier, and from the British Association for Psychopharmacology.
She has provided consultancy to NET Device Corp, received research
funding from Archimedes, Lundbeck, Pﬁzer and Schering, and holds
research grants with GlaxoSmithKline. DJ Nutt has served on the ad-
visory boards for Lundbeck, Servier, Pﬁzer, Reckitt Benkiser, D&A
Pharma, and has also received honoraria from Bristol Myers Squibb,
Glaxo Smith Kline and Schering-Plough. He has received research
funding from P1vital, has share options with P1vital, and receives ed-
itorial honoraria from Sage. AR Lingford-Hughes and DJ Nutt are both
members of the Lundbeck International Neuroscience Foundation. Dr
Stokes, Dr Wu, Ms Michalczuk, Ms Benecke, Dr Egerton, Dr Watson,
Dr Piccini and Dr Bowden-Jones have no ﬁnancial interests to declare.
Acknowledgments
This work was supported by Medical Research Council grants
G0802725 to LC and HBJ, and G0400575 to DJN and ALH. The National
Problem Gambling Clinic is supported by the Responsible Gambling
Fund. The project was completed within the Behavioural and Clinical
Neuroscience Institute, supported by a consortium award from the
MRC and Wellcome Trust (director: TW Robbins). The data were
presented at the British Association for Psychopharmacology summer
meeting, Harrogate, UK (July 2011).
References
Backman, L., Ginovart, N., Dixon, R.A., Wahlin, T.B., Wahlin, A., Halldin, C., Farde, L.,
2000. Age-related cognitive deﬁcits mediated by changes in the striatal dopamine
system. Am. J. Psychiatry 157, 635–637.
Bergh, C., Eklund, T., Sodersten, P., Nordin, C., 1997. Altered dopamine function in path-
ological gambling. Psychol. Med. 27, 473–475.
Blaszczynski, A., Nower, L., 2002. A pathways model of problem and pathological gam-
bling. Addiction 97, 487–499.
Bowden-Jones, H., Clark, L., 2011. Pathological Gambling: a neurobiological and clinical
update. Br. J. Psychiatry 199, 87–89.
Boy, F., Evans, C.J., Edden, R.A., Lawrence, A.D., Singh, K.D., Husain, M., Sumner, P., 2011.
Dorsolateral prefrontal gamma-aminobutyric acid in men predicts individual dif-
ferences in rash impulsivity. Biol. Psychiatry 70, 866–872.
Buckholtz, J.W., Treadway, M.T., Cowan, R.L., Woodward, N.D., Li, R., Ansari, M.S., Baldwin,
R.M., Schwartzman, A.N., Shelby, E.S., Smith, C.E., Kessler, R.M., Zald, D.H., 2010. Dopa-
minergic network differences in human impulsivity. Science 329, 532.Busto, U.E., Redden, L., Mayberg, H., Kapur, S., Houle, S., Zawertailo, L.A., 2009. Dopami-
nergic activity in depressed smokers: a positron emission tomography study. Syn-
apse 63, 681–689.
Carson, R.E., Breier, A., de Bartolomeis, A., Saunders, R.C., Su, T.P., Schmall, B., Der, M.G.,
Pickar, D., Eckelman, W.C., 1997. Quantiﬁcation of amphetamine-induced changes
in [11C]raclopride binding with continuous infusion. J. Cereb. Blood Flow Metab.
17, 437–447.
Chase, H.W., Clark, L., 2010. Gambling severity predicts midbrain response to near-miss
outcomes. J. Neurosci. 30, 6180–6187.
Cilia, R., Ko, J.H., Cho, S.S., van Eimeren, T., Marotta, G., Pellecchia, G., Pezzoli, G.,
Antonini, A., Strafella, A.P., 2010. Reduced dopamine transporter density in the
ventral striatum of patients with Parkinson's disease and pathological gambling.
Neurobiol. Dis. 39, 98–104.
Cools, R., D'Esposito, M., 2011. Inverted-U-shaped dopamine actions on human work-
ing memory and cognitive control. Biol. Psychiatry 69, e113–e125.
Cyders, M.A., Smith, G.T., 2008. Emotion-based dispositions to rash action: positive and
negative urgency. Psychol. Bull. 134, 807–828.
Cyders, M.A., Smith, G.T., Spillane, N.S., Fischer, S., Annus, A.M., Peterson, C., 2007. Inte-
gration of impulsivity and positive mood to predict risky behavior: development
and validation of a measure of positive urgency. Psychol. Assess. 19, 107–118.
Dalley, J.W., Fryer, T.D., Brichard, L., Robinson, E.S., Theobald, D.E., Laane, K., Pena, Y.,
Murphy, E.R., Shah, Y., Probst, K., Abakumova, I., Aigbirhio, F.I., Richards, H.K.,
Hong, Y., Baron, J.C., Everitt, B.J., Robbins, T.W., 2007. Nucleus accumbens D2/3 re-
ceptors predict trait impulsivity and cocaine reinforcement. Science 315, 1267–1270.
Di Chiara, G., Imperato, A., 1988. Drugs abused by humans preferentially increase syn-
aptic dopamine concentrations in the mesolimbic system of freely moving rats.
Proc. Natl. Acad. Sci. U. S. A. 85, 5274–5278.
Egerton, A., Mehta, M.A., Montgomery, A.J., Lappin, J.M., Howes, O.D., Reeves, S.J.,
Cunningham, V.J., Grasby, P.M., 2009. The dopaminergic basis of human behaviors:
a review of molecular imaging studies. Neurosci. Biobehav. Rev. 33, 1109–1132.
Egerton, A., Shotbolt, J.P., Stokes, P.R., Hirani, E., Ahmad, R., Lappin, J.M., Reeves, S.J.,
Mehta, M.A., Howes, O.D., Grasby, P.M., 2010. Acute effect of the anti-addiction
drug bupropion on extracellular dopamine concentrations in the human striatum:
an [11C]raclopride PET study. Neuroimage 50, 260–266.
Ersche, K.D., Turton, A.J., Pradhan, S., Bullmore, E.T., Robbins, T.W., 2010. Drug addiction
endophenotypes: impulsive versus sensation-seeking personality traits. Biol. Psy-
chiatry 68, 770–773.
Fehr, C., Yakushev, I., Hohmann, N., Buchholz, H.G., Landvogt, C., Deckers, H., Eberhardt,
A., Klager, M., Smolka, M.N., Scheurich, A., Dielentheis, T., Schmidt, L.G., Rosch, F.,
Bartenstein, P., Grunder, G., Schreckenberger, M., 2008. Association of low striatal
dopamine d2 receptor availability with nicotine dependence similar to that seen
with other drugs of abuse. Am. J. Psychiatry 165, 507–514.
Ferris, J., Wynne, H., 2001. Canadian Problem Gambling Index. Canadian Centre on Sub-
stance Abuse, Ottawa, Ontario.
Fong, T., Kalechstein, A., Bernhard, B., Rosenthal, R., Rugle, L., 2008. A double-blind,
placebo-controlled trial of olanzapine for the treatment of video poker pathologi-
cal gamblers. Pharmacol. Biochem. Behav. 89, 298–303.
Frascella, J., Potenza, M.N., Brown, L.L., Childress, A.R., 2010. Shared brain vulnerabil-
ities open the way for nonsubstance addictions: carving addiction at a new
joint? Ann. N. Y. Acad. Sci. 1187, 294–315.
Gjedde, A., Kumakura, Y., Cumming, P., Linnet, J., Moller, A., 2010. Inverted-U-shaped
correlation between dopamine receptor availability in striatum and sensation
seeking. Proc. Natl. Acad. Sci. U. S. A. 107, 3870–3875.
Heinz, A., Siessmeier, T., Wrase, J., Hermann, D., Klein, S., Grusser, S.M., Flor, H., Braus,
D.F., Buchholz, H.G., Grunder, G., Schreckenberger, M., Smolka, M.N., Rosch, F.,
Mann, K., Bartenstein, P., 2004. Correlation between dopamine D(2) receptors in
the ventral striatum and central processing of alcohol cues and craving. Am. J. Psy-
chiatry 161, 1783–1789.
Innis, R.B., Cunningham, V.J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R.N., Holden, J.,
Houle, S., Huang, S.C., Ichise, M., Iida, H., Ito, H., Kimura, Y., Koeppe, R.A., Knudsen,
G.M., Knuuti, J., Lammertsma, A.A., Laruelle, M., Logan, J., Maguire, R.P., Mintun,
M.A., Morris, E.D., Parsey, R., Price, J.C., Slifstein, M., Sossi, V., Suhara, T., Votaw,
J.R., Wong, D.F., Carson, R.E., 2007. Consensus nomenclature for in vivo imaging of
reversibly binding radioligands. J. Cereb. Blood Flow Metab. 27, 1533–1539.
Ito, H., Hietala, J., Blomqvist, G., Halldin, C., Farde, L., 1998. Comparison of the transient
equilibrium and continuous infusion method for quantitative PET analysis of [11C]
raclopride binding. J. Cereb. Blood Flow Metab. 18, 941–950.
Joutsa, J., Johansson, J., Niemela, S., Ollikainen, A., Hirvonen, M.M., Piepponen, P.,
Arponen, E., Alho, H., Voon, V., Rinne, J.O., Hietala, J., Kaasinen, V., 2012. Mesolimbic
dopamine release is linked to symptom severity in pathological gambling.
Neuroimage 60, 1992–1999.
Kessler, R.C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N.A., Winters, K.C., Shaffer,
H.J., 2008. DSM-IV pathological gambling in the National Comorbidity Survey Rep-
lication. Psychol. Med. 38, 1351–1360.
Kim, J.H., Son, Y.D., Kim, H.K., Lee, S.Y., Cho, S.E., Kim, Y.B., Cho, Z.H., 2011. Effects of age
on dopamine D(2) receptor availability in striatal subdivisions: A high-resolution
positron emission tomography study. Eur. Neuropsychopharmacol. 21, 885–891.
Lee, B., London, E.D., Poldrack, R.A., Farahi, J., Nacca, A., Monterosso, J.R., Mumford, J.A.,
Bokarius, A.V., Dahlbom, M., Mukherjee, J., Bilder, R.M., Brody, A.L., Mandelkern,
M.A., 2009. Striatal dopamine d2/d3 receptor availability is reduced in metham-
phetamine dependence and is linked to impulsivity. J. Neurosci. 29, 14734–14740.
Leeman, R.F., Potenza, M.N., 2012. Similarities and differences between pathological
gambling and substance use disorders: a focus on impulsivity and compulsivity.
Psychopharmacology (Berl) 219, 469–490.
Lesieur,H.R., Blume, S.B., 1987. TheSouthOaksGambling Screen (SOGS): a new instrument
for the identiﬁcation of pathological gamblers. Am. J. Psychiatry 144, 1184–1188.
46 L. Clark et al. / NeuroImage 63 (2012) 40–46Linnet, J., Moller, A., Peterson, E., Gjedde, A., Doudet, D., 2011. Dopamine release in ven-
tral striatum during Iowa Gambling Task performance is associated with increased
excitement levels in pathological gambling. Addiction 106, 383–390.
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.R., Huang, Y., Cooper, T.,
Kegeles, L., Zarahn, E., Abi-Dargham, A., Haber, S.N., Laruelle, M., 2003. Imaging
human mesolimbic dopamine transmission with positron emission tomography.
Part II: amphetamine-induced dopamine release in the functional subdivisions of
the striatum. J. Cereb. Blood Flow Metab. 23, 285–300.
Martinez, D., Broft, A., Foltin, R.W., Slifstein, M., Hwang, D.R., Huang, Y., Perez, A., Frankle,
W.G., Cooper, T., Kleber, H.D., Fischman,M.W., Laruelle,M., 2004. Cocaine dependence
and d2 receptor availability in the functional subdivisions of the striatum: relationship
with cocaine-seeking behavior. Neuropsychopharmacology 29, 1190–1202.
Martinez, D., Greene, K., Broft, A., Kumar, D., Liu, F., Narendran, R., Slifstein, M., Van
Heertum, R., Kleber, H.D., 2009. Lower level of endogenous dopamine in patients
with cocaine dependence: ﬁndings from PET imaging of D(2)/D(3) receptors fol-
lowing acute dopamine depletion. Am. J. Psychiatry 166, 1170–1177.
Matsumoto, M., Togashi, H., Kaku, A., Kanno, M., Tahara, K., Yoshioka, M., 2005. Cortical
GABAergic regulation of dopaminergic responses to psychological stress in the rat
dorsolateral striatum. Synapse 56, 117–121.
McElroy, S.L., Nelson, E.B., Welge, J.A., Kaehler, L., Keck Jr., P.E., 2008. Olanzapine in the
treatment of pathological gambling: a negative randomized placebo-controlled
trial. J. Clin. Psychiatry 69, 433–440.
Meyer, G., Schwertfeger, J., Exton, M.S., Janssen, O.E., Knapp, W., Stadler, M.A.,
Schedlowski, M., Kruger, T.H., 2004. Neuroendocrine response to casino gambling
in problem gamblers. Psychoneuroendocrinology 29, 1272–1280.
Michalczuk, R., Bowden-Jones, H., Verdejo-Garcia, A., Clark, L., 2011. Impulsivity and
cognitive distortions in pathological gamblers attending the UK National Problem
Gambling Clinic: a preliminary report. Psychol. Med. 41, 2625–2635.
Montgomery, A.J., Thielemans, K., Mehta, M.A., Turkheimer, F., Mustafovic, S., Grasby,
P.M., 2006. Correction of head movement on PET studies: comparison of methods.
J. Nucl. Med. 47, 1936–1944.
Nader, M.A., Morgan, D., Gage, H.D., Nader, S.H., Calhoun, T.L., Buchheimer, N.,
Ehrenkaufer, R., Mach, R.H., 2006. PET imaging of dopamine D2 receptors during
chronic cocaine self-administration in monkeys. Nat. Neurosci. 9, 1050–1056.
O'Sullivan, S.S., Wu, K., Politis, M., Lawrence, A.D., Evans, A.H., Bose, S.K., Djamshidian,
A., Lees, A.J., Piccini, P., 2011. Cue-induced striatal dopamine release in Parkinson's
disease-associated impulsive-compulsive behaviours. Brain 134, 969–978.
Reuter, J., Raedler, T., Rose, M., Hand, I., Glascher, J., Buchel, C., 2005. Pathological gam-
bling is linked to reduced activation of the mesolimbic reward system. Nat.
Neurosci. 8, 147–148.
Shaffer, H.J., LaBrie, R., Scanlan, K.M., Cummings, T.N., 1994. Pathological Gambling among
adolescents: Massachusetts Gambling Screen (MAGS). J. Gambl. Stud. 10, 339–362.Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta,
T., Baker, R., Dunbar, G.C., 1998. The Mini-International Neuropsychiatric Interview
(M.I.N.I.): the development and validation of a structured diagnostic psychiatric
interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (Suppl. 20), 22–33.
Slutske, W.S., Caspi, A., Mofﬁtt, T.E., Poulton, R., 2005. Personality and problem gam-
bling: a prospective study of a birth cohort of young adults. Arch. Gen. Psychiatry
62, 769–775.
Smith, N., Kitchenham, N., Bowden-Jones, H., 2011. Pathological gambling and the treat-
ment of psychosis with aripiprazole: case reports. Br. J. Psychiatry 199, 158–159.
Steeves, T.D., Miyasaki, J., Zurowski, M., Lang, A.E., Pellecchia, G., Van Eimeren, T.,
Rusjan, P., Houle, S., Strafella, A.P., 2009. Increased striatal dopamine release in
Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
Brain 132, 1376–1385.
Stewart, S.H., Zack, M., 2008. Development and psychometric evaluation of a three-
dimensional Gambling Motives Questionnaire. Addiction 103, 1110–1117.
Stokes, P.R., Egerton, A., Watson, B., Reid, A., Breen, G., Lingford-Hughes, A., Nutt, D.J.,
Mehta, M.A., 2010. Signiﬁcant decreases in frontal and temporal [11C]-raclopride
binding after THC challenge. Neuroimage 52, 1521–1527.
Verdejo-Garcia, A., Lawrence, A.J., Clark, L., 2008. Impulsivity as a vulnerability marker
for substance-use disorders: review of ﬁndings from high-risk research, problem
gamblers and genetic association studies. Neurosci. Biobehav. Rev. 32, 777–810.
Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, S.J., Hitzemann, R., Chen, A.D.,
Dewey, S.L., Pappas, N., 1997. Decreased striatal dopaminergic responsiveness in
detoxiﬁed cocaine-dependent subjects. Nature 386, 830–833.
Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, S.J., Gifford, A., Hitzemann, R., Ding,
Y.S., Pappas, N., 1999. Prediction of reinforcing responses to psychostimulants in
humans by brain dopamine D2 receptor levels. Am. J. Psychiatry 156, 1440–1443.
Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Ding, Y.S., Sedler, M., Logan, J.,
Franceschi, D., Gatley, J., Hitzemann, R., Gifford, A., Wong, C., Pappas, N., 2001.
Low level of brain dopamine D2 receptors in methamphetamine abusers: associa-
tion with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158, 2015–2021.
Voon, V., Fernagut, P.O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J.L.,
Obeso, J.A., Bezard, E., 2009. Chronic dopaminergic stimulation in Parkinson's dis-
ease: from dyskinesias to impulse control disorders. Lancet Neurol. 8, 1140–1149.
Wang, G.J., Volkow, N.D., Logan, J., Pappas, N.R., Wong, C.T., Zhu, W., Netusil, N., Fowler,
J.S., 2001. Brain dopamine and obesity. Lancet 357, 354–357.
Watabe, H., Endres, C.J., Breier, A., Schmall, B., Eckelman, W.C., Carson, R.E., 2000. Mea-
surement of dopamine release with continuous infusion of [11C]raclopride: opti-
mization and signal-to-noise considerations. J. Nucl. Med. 41, 522–530.
Zald, D.H., Boileau, I., El-Dearedy, W., Gunn, R., McGlone, F., Dichter, G.S., Dagher, A.,
2004. Dopamine transmission in the human striatum during monetary reward
tasks. J. Neurosci. 24, 4105–4112.
